Sotera Health (SHC)
(Delayed Data from NSDQ)
$16.13 USD
-0.67 (-3.99%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $16.13 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum F VGM
Income Statements
Fiscal Year end for Sotera Health Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,049 | 1,004 | 931 | 818 | 778 |
Cost Of Goods | 472 | 447 | 413 | 375 | 383 |
Gross Profit | 577 | 557 | 519 | 444 | 395 |
Selling & Adminstrative & Depr. & Amort Expenses | 300 | 309 | 262 | 238 | 212 |
Income After Depreciation & Amortization | 277 | 248 | 257 | 206 | 184 |
Non-Operating Income | -28 | -411 | -7 | -30 | -27 |
Interest Expense | 143 | 80 | 74 | 215 | 158 |
Pretax Income | 106 | -243 | 176 | -39 | -1 |
Income Taxes | 55 | -10 | 59 | -1 | 20 |
Minority Interest | 0 | 0 | 0 | 1 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 51 | -234 | 117 | -37 | -20 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 51 | -234 | 117 | -39 | -21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 444 | 409 | 414 | 361 | 339 |
Depreciation & Amortization (Cash Flow) | 167 | 161 | 157 | 155 | 155 |
Income After Depreciation & Amortization | 277 | 248 | 257 | 206 | 184 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 283.22 | 280.10 | 279.38 | 237.70 | NA |
Diluted EPS Before Non-Recurring Items | 0.72 | 0.90 | 0.84 | 0.38 | NA |
Diluted Net EPS (GAAP) | 0.18 | -0.83 | 0.41 | -0.16 | -0.09 |
Fiscal Year end for Sotera Health Company falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 276.59 | 248.18 | 310.24 | 263.18 | 255.28 |
Cost Of Goods | 123.80 | 121.06 | 130.16 | 117.19 | 115.69 |
Gross Profit | 152.79 | 127.12 | 180.08 | 145.98 | 139.59 |
SG&A, R&D, and Dept/Amort Expenses | 76.00 | 73.94 | 76.06 | 69.88 | 76.39 |
Income After SG&A, R&D, and Dept/Amort Expenses | 76.79 | 53.18 | 104.02 | 76.10 | 63.20 |
Non-Operating Income | -21.27 | -0.39 | 4.30 | -35.00 | 2.01 |
Interest Expense | 40.39 | 41.77 | 42.65 | 40.63 | 30.73 |
Pretax Income | 15.14 | 11.01 | 65.67 | 0.47 | 34.49 |
Income Taxes | 6.39 | 4.69 | 26.99 | 14.13 | 10.97 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 8.75 | 6.32 | 38.68 | -13.66 | 23.51 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 8.75 | 6.32 | 38.68 | -13.66 | 23.51 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 284.54 | 284.06 | 283.34 | 281.11 | 283.15 |
Diluted EPS Before Non-Recurring Items | 0.17 | 0.11 | 0.24 | 0.18 | 0.19 |
Diluted Net EPS (GAAP) | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 |